tenofovir has been researched along with hydroxyethylcellulose in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Black, CM; Chaney, DM; Doncel, GF; Gallo, MF; Jamieson, DJ; Kourtis, AP; Macaluso, M; Mauck, CK; Melendez, JH; Penman-Aguilar, A; Snead, MC | 1 |
Anton, PA; Bumpus, NN; Cranston, RD; Elliott, J; Hendrix, CW; Kashuba, A; Mauck, C; McGowan, I; Richardson-Harman, N; Tanner, K; Yang, K | 1 |
Archer, DF; Doncel, GF; Jacot, TA; Kashuba, AD; Nelson, A; Thurman, A | 1 |
1 trial(s) available for tenofovir and hydroxyethylcellulose
Article | Year |
---|---|
Correlation between compartmental tenofovir concentrations and an ex vivo rectal biopsy model of tissue infectibility in the RMP-02/MTN-006 phase 1 study.
Topics: Administration, Oral; Administration, Rectal; Adult; Biopsy; Cellulose; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gels; HIV Infections; Humans; Male; Rectum; Tenofovir; Vaginal Creams, Foams, and Jellies; Young Adult | 2014 |
2 other study(ies) available for tenofovir and hydroxyethylcellulose
Article | Year |
---|---|
Does tenofovir gel or do other microbicide products affect detection of biomarkers of semen exposure in vitro?
Topics: Adenine; Anilides; Antibiotic Prophylaxis; Biomarkers; Cellulose; Chromosomes, Human, Y; DNA; Excipients; False Positive Reactions; Female; Furans; Humans; Limit of Detection; Organophosphonates; Osmolar Concentration; Prostate-Specific Antigen; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Reverse Transcriptase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Semen; Tenofovir; Thioamides; Vaginal Creams, Foams, and Jellies | 2014 |
Development of a composite measure of product adherence, protocol compliance, and semen exposure using DNA and protein biomarkers for topical HIV prevention studies.
Topics: Adenine; Administration, Topical; Adult; Anti-HIV Agents; Biomarkers; Cellulose; DNA; Environmental Exposure; Feasibility Studies; Female; Guideline Adherence; HIV Infections; Humans; Keratin-4; Male; Middle Aged; Organophosphonates; Outcome Assessment, Health Care; Patient Compliance; Semen; Tenofovir; Vagina; Young Adult | 2014 |